EISSENSTAT MICHAEL has a total of 11 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TRANSLATIONAL DRUG DEV LLC, SYMPHONY EVOLUTION INC and OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTYU FARMINTERPRAJSEZ.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Foods and drinks | |
#6 | Environmental technology | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Computational chemistry | |
#7 | Bioinformatics | |
#8 | Enzymes | |
#9 | Unspecified technologies | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Eissenstat Michael | 11 |
#2 | Duan Dehui | 6 |
#3 | Erickson John W | 3 |
#4 | Kang Sang Uk | 2 |
#5 | Lu Rongjian | 2 |
#6 | Silva Abelardo | 1 |
#7 | Gulnik Sergei | 1 |
#8 | Kang Ji-Hye | 1 |
#9 | Gulnik Sergi | 1 |
#10 | Kang Jihye | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010135748A1 | Bimacrocyclic hcv ns3 protease inhibitors | |
US2011182854A1 | HCV protease inhibitors |